BMAL1 and atherosclerosis: Pan et al. found that both the global and hepatic Bmal1 deficiency enhances atherosclerosis in Apoe−/− mice and demonstrated that Bmal1 is an anti‐atherogenic transcription factor for its important contribution to lipoprotein and cholesterol metabolism (Pan et al., 2016).